Focus on Women's and Men’s Health

Host: Ayse Tuba Kendi, MD

Guest: A. Oliver Sartor, MD

Prostate-specific membrane antigen (PSMA) is highly expressed on prostate cancer (PC) cells and can be detected in tumors using positron emission tomography imaging. Even though clinical features predict different stages of PC progression, the application of imaging to guide treatment is still evolving but gaining substantial evidence for the targeting of PSMA. With clinical research shifting paradigms for the treatment of metastatic castration-resistant prostate cancer (mCRPC), novel treatment options require adoption and effective application into clinical practice. PSMA has become an appealing target for diagnostic agents for imaging and therapeutic agents to treat mCRPC. Radionuclide emitters are being used for both cell surface expression of PSMA and the tumor microenvironment, and research has proven the therapeutic efficacy of PSMA-directed radioligand therapy (RLT).

In this educational activity, two experts will examine the role and rationale for PSMA targeted therapies and diagnostics—jointly known as theragnostics—as a revolutionary new approach to treating patients with advanced prostate cancer and will evaluate clinical trial data for PSMA-targeted RLT.

Host: Paul Doghramji, MD

Guest: Megan Arnot

Menopause is an inevitable transition in every woman’s life, but what if engaging in a basic physiological need like sex could delay its onset? Researching this potential connection is Megan Arnot, a Ph.D. candidate in the Department of Anthropology at the University College London. As the lead author of the study, she walks us through her findings and the range of factors they investigated, like the type of sexual activity and whether or not women lived with a partner.

Host: Jennifer Caudle, DO

Guest: Frank LoVecchio, DO, MPH, FACEP

Guest: Casey Lafferty, DO

Due to the high prevalence of influenza each winter, knowing how to treat those most at risk is essential. That's why Dr. Frank LoVecchio and Dr. Casey Lafferty are here to discuss the 2019-2020 flu season activity and patterns, along with preventive tips and treatment options you can provide to your patients.

Host: Jennifer Caudle, DO

Guest: Frank LoVecchio, DO, MPH, FACEP

The cold weather inevitably brings an increase in flu cases each year, and joining Dr. Jennifer Caudle to unveil the high-risk populations—and how we can treat the members of those vulnerable populations who do get the flu—is Dr. Frank LoVecchio, Professor of Emergency Medicine at the University of Arizona and Principal Investigator for the Infectious Disease Network.

Host: Jennifer Caudle, DO

Guest: Liza Kunz, MD, FACOG

Amid the expanding noninvasive prenatal testing (NIPT) options, Dr. Liza Kunz joins Dr. Jennifer Caudle to discuss what differentiates genome-wide NIPT from other options, how it works, and its limitations and potential benefits.

US MSA Educational Program

Guest: Sheryl A. Kingsberg, PhD

Guest: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF

Guest: Risa Kagan, MD, FACOG, CCD, NCMP

Guest: James A. Simon, MD, CCD, NCMP, IF, FACOG

An average of 37.5 million menopausal women in the US between the ages of 45 and 64 experience symptoms such as hot flashes and joint pain, but there are other symptoms that we rarely talk about: symptoms like vaginal dryness and dyspareunia.

Featuring a patient and a panel of experts, this discussion reviews strategies that can be used to help patients feel comfortable in bringing up their struggles with menopause along with how we can help relieve women from their pain.

©2019 NP-INR-US-00214 09/19

Host: Amy Mackey, MD

Guest: Maria Trent, MD, MPH, FAAP, FSAHM

Even though molecular assays are quickly becoming the standard of care for the diagnosis of Mycoplasma genitalium and other infectious conditions, there’s still much more to be shared and learned about how to rapidly identify this infection. And here to start that discussion is Dr. Maria Trent, Professor of Pediatrics in the Division of General Pediatrics and Adolescent Medicine at Johns Hopkins School of Medicine.

Click here to learn more about other women's health programs in this special series.

Host: Mario R. Nacinovich, Jr., MSc

Guest: Kara Rood, MD

A recent study following 346 pregnant patients found that 63 percent of the women were admitted into the hospital for uncertain diagnosis or delivery—all because preeclampsia has many of the same symptoms of other diseases. The good news, however, is that there’s a new test currently underway that could make the diagnosis and treatment of preeclampsia easier in order to prevent potentially dangerous outcomes for the mother and baby, as OB/GYN Dr. Kara Rood explains.

Host: Scott Kopetz, MD, PhD, FACP

Guest: Alberto Sobrero, MD

Guest: Rui-Hua Xu, MD

El cáncer colorrectal metastásico es difícil de tratar y presenta varias mutaciones genéticas, expresiones y amplificaciones, tal como la lateralidad del tumor. Y, tal como explican el Dr. Scott Kopetz, el Dr. Rui-Hua Xu y el Dr. Alberto Sobrero, aunque identificar estas distinciones puede resultar una tarea difícil, al hacerlo se averiguan pistas esenciales para decidir cuál es la mejor opción de tratamiento para cada paciente.

Host: Scott Kopetz, MD, PhD, FACP

Guest: Alberto Sobrero, MD

Guest: Rui-Hua Xu, MD

O cancro colorretal metastático é difícil de gerir e tem múltiplas mutações genéticas, expressões e amplificações, tais como o lado do tumor. E, apesar dos desafios em identificar estas distinções, estas também oferecem pistas essenciais sobre qual a melhor opção de tratamento para cada doente, tal como explicam o Dr. Scott Kopetz, o Dr. Rui-Hua Xu e o Dr. Alberto Sobrero.